A Phase 1 trial of BP1002 in patients with Non-Hodgkin's Lymphoma

Trial Profile

A Phase 1 trial of BP1002 in patients with Non-Hodgkin's Lymphoma

Planning
Phase of Trial: Phase I

Latest Information Update: 12 Apr 2017

At a glance

  • Drugs BP 1002 (Primary)
  • Indications Non-Hodgkin's lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Apr 2017 New trial record
    • 05 Apr 2017 According to a Bio-Path Holdings media release, company is planning to submit an investigational new drug (IND) application for BP1002 and initiate this trial later in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top